Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -18.00% is 83% above its 5-year average of -103.06%, near the high end of its 5-year range (-618.78%–74.14%).
328.69% below its 12-month average of 7.87%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 32.72%.
OPERATING MARGIN
-18.00%
OPERATING MARGIN AVG TTM
7.87%
OPERATING MARGIN AVG 3Y
-68.88%
OPERATING MARGIN AVG 5Y
-103.06%
OPERATING MARGIN AVG 10Y
-140.44%
OPERATING MARGIN AVG 15Y
-316.46%
OPERATING MARGIN AVG 20Y
-461.36%
CURRENT VS TTM AVG
-328.69%
CURRENT VS 3Y AVG
+73.87%
CURRENT VS 5Y AVG
+82.53%
CURRENT VS 10Y AVG
+87.18%
CURRENT VS 15Y AVG
+94.31%
CURRENT VS 20Y AVG
+96.10%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Agenus Inc.
Market Cap
$363.54M
Operating Margin
-18.00%
TTM Avg
7.87%
3Y Avg
-68.88%
5Y Avg
-103.06%
Market Cap
$366.39M
Operating Margin
-130.65%
TTM Avg
-155.28%
3Y Avg
-156.88%
5Y Avg
-129.07%
Market Cap
$368.91M
Operating Margin
-14.22%
TTM Avg
-4.51%
3Y Avg
-387.94%
5Y Avg
-2012.06%
Market Cap
$373.40M
Operating Margin
-31.98%
TTM Avg
-34.62%
3Y Avg
-233.89%
5Y Avg
-229.53%
Market Cap
$348.85M
Operating Margin
24.85%
TTM Avg
23.00%
3Y Avg
24.99%
5Y Avg
31.17%
Market Cap
$348.59M
Operating Margin
0.00%
TTM Avg
-13402.79%
3Y Avg
-7027.62%
5Y Avg
-5128.57%
Market Cap
$345.48M
Operating Margin
-65.36%
TTM Avg
-64.13%
3Y Avg
-75.36%
5Y Avg
-72.00%
Market Cap
$339.15M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$330.60M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agenus Inc. (AGEN) | $363.54M | -18.00% | 7.87% | -68.88% | -103.06% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -130.65% | -155.28% | -156.88% | -129.07% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -14.22% | -4.51% | -387.94% | -2012.06% |
| Canopy Growth Corporation (CGC)vs › | $373.40M | -31.98% | -34.62% | -233.89% | -229.53% |
| Embecta Corp. (EMBC)vs › | $348.85M | 24.85% | 23.00% | 24.99% | 31.17% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | 0.00% | -13402.79% | -7027.62% | -5128.57% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -65.36% | -64.13% | -75.36% | -72.00% |
| Cabaletta Bio, Inc. (CABA)vs › | $339.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $330.60M | -290.68% | -313.41% | -428.31% | -345.79% |
| CapsoVision, Inc. (CV)vs › | $329.01M | -188.25% | -178.83% | -158.00% | -158.00% |
Gross Margin
29.6%
Operating Margin
-18.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 32.72% |
| 2026-03-31 | 44.62% |
| 2025-12-31 | 42.09% |
| 2025-09-30 | -15.03% |
| 2025-06-30 | -65.05% |
| 2025-03-31 | -55.31% |
| 2024-12-31 | -96.49% |
| 2024-09-30 | -125.45% |
| 2024-06-30 | -128.43% |
| 2024-03-31 | -117.41% |
| 2023-12-31 | -5.01% |
| 2023-09-30 | -190.59% |
| 2023-06-30 | -216.11% |
| 2023-03-31 | -237.28% |
| 2022-12-31 | -203.47% |
| 2022-09-30 | -182.88% |
| 2022-06-30 | -212.96% |
| 2022-03-31 | -136.70% |
| 2021-12-31 | -266.66% |
| 2021-09-30 | 74.14% |
| 2021-06-30 | -618.78% |
| 2021-03-31 | -353.03% |
| 2020-12-31 | -69.43% |
| 2020-09-30 | -234.55% |
| 2020-06-30 | -123.49% |
| 2020-03-31 | -181.54% |
| 2019-12-31 | -55.87% |
| 2019-09-30 | -180.16% |
| 2019-06-30 | -261.83% |
| 2019-03-31 | 32.80% |
| 2018-12-31 | -611.20% |
| 2018-09-30 | -203.67% |
| 2018-06-30 | -104.26% |
| 2018-03-31 | -2551.82% |
| 2017-12-31 | -359.01% |
| 2017-09-30 | -942.55% |
| 2017-06-30 | -686.67% |
| 2017-03-31 | -49.18% |
| 2016-12-31 | -352.87% |
| 2016-09-30 | -814.75% |
| 2016-06-30 | -358.13% |
| 2016-03-31 | -469.36% |
| 2015-12-31 | -237.56% |
| 2015-09-30 | -161.62% |
| 2015-06-30 | -520.54% |
| 2015-03-31 | -462.74% |
| 2014-12-31 | -1090.74% |
| 2014-09-30 | -490.73% |
| 2014-06-30 | -267.40% |
| 2014-03-31 | -1362.55% |
| 2013-12-31 | -1584.48% |
| 2013-09-30 | -925.95% |
| 2013-06-30 | -908.18% |
| 2013-03-31 | -415.60% |
| 2012-12-31 | -387.98% |
| 2012-09-30 | -522.55% |
| 2012-06-30 | -920.41% |
| 2012-03-31 | 58.32% |
| 2011-12-31 | -764.54% |
| 2011-09-30 | -679.37% |
| 2011-06-30 | -598.22% |
| 2011-03-31 | -747.52% |
| 2010-12-31 | -498.78% |
| 2010-09-30 | -782.60% |
| 2010-06-30 | -577.39% |
| 2010-03-31 | -775.39% |
| 2009-12-31 | -950.41% |
| 2009-09-30 | -710.22% |
| 2009-06-30 | -624.28% |
| 2009-03-31 | -1317.71% |
| 2008-12-31 | -1316.44% |
| 2008-09-30 | -1437.91% |
| 2008-06-30 | -1846.37% |
| 2008-03-31 | -1194.21% |
| 2007-12-31 | -725.40% |
| 2007-09-30 | -1141.85% |
| 2007-06-30 | -623.70% |
| 2007-03-31 | -337.65% |
| 2006-12-31 | -3427.94% |
| 2006-09-30 | -4978.18% |
| 2006-06-30 | -14436.12% |
| 2006-03-31 | -25012.82% |
| 2005-12-31 | -5077.81% |
| 2005-09-30 | -22414.74% |
| 2005-06-30 | -24896.86% |
| 2005-03-31 | -14941.09% |
| 2004-12-31 | -13462.55% |
| 2004-09-30 | -6638.42% |
| 2004-06-30 | -9126.73% |
| 2004-03-31 | -3933.43% |
| 2003-12-31 | -2012.93% |
| 2003-09-30 | -2267.41% |
| 2003-06-30 | -1795.64% |
| 2003-03-31 | -788.78% |
| 2002-12-31 | -2091.26% |
| 2002-09-30 | -1439.77% |
